Literature DB >> 23576492

Priority setting in global health: towards a minimum DALY value.

Tom Drake1.   

Abstract

Rational and analytic healthcare decision making employed by many national healthcare-funding bodies could also be expected from global health donors. Cost effectiveness analysis of healthcare investment options presents the effectiveness of a particular action in proportion to the resources required, and cost effectiveness thresholds, while somewhat arbitrary, define the level at which the investment can be considered value for money. Currently, cost effectiveness thresholds reflect the national budget context or willingness-to-pay, which is problematic when making cross-country comparisons. Defining a global minimum monetary value for the disability adjusted life year (DALY) would in effect set a global baseline cost effectiveness threshold. A global minimum DALY value would reflect a universal minimum value on human health, irrespective of a national provider's willingness or ability to pay. A minimum DALY value and associated threshold has both limitations and flaws but is justified on similar grounds to the Millennium Development Goals or the absolute poverty threshold and has the potential to radically improve transparency and efficiency of priority setting in global health.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  DALY; cost effectiveness threshold; global health; priority setting

Mesh:

Year:  2013        PMID: 23576492     DOI: 10.1002/hec.2925

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  8 in total

1.  Forecasting and Analyzing the Disease Burden of Aged Population in China, Based on the 2010 Global Burden of Disease Study.

Authors:  Chengzhen Bao; Mamat Mayila; Zhenhua Ye; Jianbing Wang; Mingjuan Jin; Wenjiong He; Kun Chen
Journal:  Int J Environ Res Public Health       Date:  2015-06-25       Impact factor: 3.390

Review 2.  Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review.

Authors:  Neily Zakiyah; Antoinette D I van Asselt; Frank Roijmans; Maarten J Postma
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

3.  Malaria and Economic Evaluation Methods: Challenges and Opportunities.

Authors:  Tom L Drake; Yoel Lubell
Journal:  Appl Health Econ Health Policy       Date:  2017-06       Impact factor: 2.561

4.  Cost effectiveness and resource allocation of Plasmodium falciparum malaria control in Myanmar: a modelling analysis of bed nets and community health workers.

Authors:  Tom L Drake; Shwe Sin Kyaw; Myat Phone Kyaw; Frank M Smithuis; Nicholas P J Day; Lisa J White; Yoel Lubell
Journal:  Malar J       Date:  2015-09-29       Impact factor: 2.979

Review 5.  Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: a systematic review.

Authors:  Lindsay Mangham-Jefferies; Catherine Pitt; Simon Cousens; Anne Mills; Joanna Schellenberg
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-22       Impact factor: 3.007

Review 6.  Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review.

Authors:  Tom L Drake; Angela Devine; Shunmay Yeung; Nicholas P J Day; Lisa J White; Yoel Lubell
Journal:  Health Econ       Date:  2016-01-17       Impact factor: 3.046

7.  Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?

Authors:  Ulla Kou Griffiths; Rosa Legood; Catherine Pitt
Journal:  Health Econ       Date:  2016-01-17       Impact factor: 3.046

8.  Buy now, saved later? The critical impact of time-to-pandemic uncertainty on pandemic cost-effectiveness analyses.

Authors:  Tom Drake; Zaid Chalabi; Richard Coker
Journal:  Health Policy Plan       Date:  2013-12-24       Impact factor: 3.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.